BP 1-102

CAS : 1334493-07-0

Ref. 3D-JDC49307

Informations sur le produit

• Nom: BP 1-102
• CAS: 1334493-07-0

Description

BP 1-102 is a monoclonal antibody that targets PD-L1. It binds to PD-L1, blocking the interaction between PD-L1 and its ligands such as PD-1, B7-H3, and B7-H4. This prevents the inhibitory signals from reaching T cells and other immune cells, leading to an increase in T cell proliferation and activation. BP 1-102 has been shown to have minimal toxicity in animal studies. The drug was well tolerated with no significant changes in body weight or organ weight measurements. BP 1-102 also showed efficacy in preclinical models of cancer by inhibiting tumor growth and increasing cancer cell death (apoptosis). In addition, BP 1-102 has been shown to have an anti-inflammatory effect on IL17a production by T cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 626.59 g/mol
• Formule: C₂₉H₂₇F₅N₂O₆S
• Degré de pureté: Min. 95%